Hyung Heon Kim is CEO & President of NeuroBo Pharmaceuticals, Inc.. Currently has a direct ownership of 63,799 shares of NRBO, which is worth approximately $143,547. The most recent transaction as insider was on Nov 30, 2024, when has been sold 2,867 shares (Common Stock) at a price of $2.55 per share, resulting in proceeds of $7,310. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.8K
4.3% 3M change
89.79% 12M change
Total Value Held $143,547

Hyung Heon Kim Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 30 2024
SELL
Payment of exercise price or tax liability
$7,310 $2.55 p/Share
2,867 Reduced 4.3%
63,799 Common Stock
Aug 11 2024
SELL
Payment of exercise price or tax liability
$41,281 $3.6 p/Share
11,467 Reduced 14.68%
66,666 Common Stock
Aug 11 2023
BUY
Grant, award, or other acquisition
-
625,064 Added 50.0%
625,064 Common Stock
HHK

Hyung Heon Kim

CEO & President
Boston, MA

Track Institutional and Insider Activities on NRBO

Follow NeuroBo Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRBO shares.

Notify only if

Insider Trading

Get notified when an Neuro Bo Pharmaceuticals, Inc. insider buys or sells NRBO shares.

Notify only if

News

Receive news related to NeuroBo Pharmaceuticals, Inc.

Track Activities on NRBO